The role of neuronal NO synthase (nNOS) in the pathophysiology of depression has been demonstrated, and in the case of antidepressants, it has been shown that they reduce NO levels in the serum of patients with depression [92]. The gene discussed is NOS1; the disease is depressive disorder.